
Poly Medicure Ltd. share price
NSE: POLYMED · Healthcare
₹1,684.30 +0.18%
Closing price data, updated 17 Nov 2026. 52-week range: -18.4% from high, +42.5% above low.
Price₹1,684.30
Market cap₹17,072 Cr
P/E53.8
P/B5.23
ROE11.0%
ROCE13.3%
Debt / equity0.11
Dividend yield0.00%
EPS₹31.29
Book value₹322.15
Operating margin18.3%
Dipscan score52 / 100
Share: WhatsAppX / TwitterTelegram
Poly Medicure Ltd. shareholding pattern
As of Sep 2026: Promoters 62.42%, FIIs 5.35%, DIIs 15.90%, Government 0.00%, Public 12.31%, Others 4.02%.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Promoters | 62.42% | 62.42% | 62.42% | 62.42% | 62.42% | 62.44% |
| FIIs | 5.35% | 5.57% | 5.91% | 9.40% | 9.77% | 11.41% |
| DIIs | 15.90% | 16.08% | 15.59% | 13.84% | 13.54% | 11.72% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 12.31% | 12.18% | 12.61% | 11.30% | 11.25% | 11.37% |
| Others | 4.02% | 3.76% | 3.47% | 3.04% | 3.02% | 3.07% |
| No. of Shareholders | 74,153 | 73,643 | 73,414 | 67,750 | 64,400 | 71,142 |
As filed by the company with the exchanges.
Returns
| 1 day | 1 week | 1 month | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| +0.18% | +4.47% | +5.98% | -7.09% | +10.74% | -18.37% |
Growth
| Sales growth, 3 years | +18.8% |
| Sales growth, 5 years | – |
| Profit growth, 3 years | +21.6% |
| Profit growth, 5 years | – |
| Latest quarter sales vs last year | +30.8% |
| Latest quarter profit vs last year | +3.6% |
Strengths and weaknesses
Weaknesses
- Company has a low return on equity of 13.3% over last 3 years.
- Debtor days have increased from 83.9 to 103 days.
Peers in Healthcare
| Company | Price | Market cap | P/E | ROE | 1 year |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | ₹1,867.50 | ₹4,48,076 Cr | 40.9 | 14.7% | +8.8% |
| Divi's Laboratories Ltd. | ₹11,080.00 | ₹2,94,139 Cr | 87.5 | 16.2% | +69.4% |
| Torrent Pharmaceuticals Ltd. | ₹4,691.20 | ₹1,78,438 Cr | 84.0 | 27.1% | +22.6% |
| Apollo Hospitals Enterprise Lt | ₹8,771.00 | ₹1,26,114 Cr | 56.2 | 21.9% | +16.9% |
| Laurus Labs Ltd. | ₹2,220.00 | ₹1,19,949 Cr | 89.5 | 18.2% | +125.2% |
| Zydus Lifesciences Ltd. | ₹1,192.00 | ₹1,18,902 Cr | 28.4 | 19.7% | +27.0% |
| Dr. Reddy's Laboratories Ltd. | ₹1,377.90 | ₹1,14,778 Cr | 41.0 | 12.1% | +13.7% |
| Cipla Ltd. | ₹1,394.50 | ₹1,12,658 Cr | 38.9 | 11.8% | -8.0% |
Frequently asked questions
What is the share price of Poly Medicure Ltd.?
Poly Medicure Ltd. (POLYMED) last closed at ₹1,684.30 (+0.18% on the day).
What is the market cap of Poly Medicure Ltd.?
About ₹17,072 Cr.
What is the P/E ratio of Poly Medicure Ltd.?
The price-to-earnings ratio is 53.8, and return on equity is 11.0%.
Figures are calculated from company results and exchange prices and are for information only.